Skip to content
Search

Latest Stories

LOG Pharma expands manufacturing site with ‘multi-million-dollar’ modern clean room

LOG Pharma expands manufacturing site with ‘multi-million-dollar’ modern clean room

Equipped with advanced automated online inspection, LOG Pharma’s new facility is designed to meet the high standards of pharmaceutical companies. 

LOG Pharma Primary Packaging, a global leader in pharmaceutical packaging solutions, has unveiled a new, multi-million-dollar, state-of-the-art clean room at its manufacturing site in Kibbutz Ashdot Ya’acov Ichud, Israel.

The new facility, part of a broader 600-square meter expansion of the company’s manufacturing site, is designed to meet the high standards of pharmaceutical companies.


With this ISO 8-certified clean room and newly expanded facility, LOG Pharma aims to enhance productivity for global innovative and generic pharmaceutical companies by offering high-quality barrier packaging solutions, tailored to precise product specifications.

The facility is equipped with cutting-edge automated online inspection, ensuring immediate and reliable detection of any defects, thus enhancing the production of LOG’s innovative and sustainable packaging solutions.

Shaul Bassi, CEO of LOG Pharma, said: “The massive investment in the new clean room emphasizes our commitment to meet and exceed customer expectations and further strengthens LOG’s position as a leading primary packaging provider for the pharmaceutical industry.”

“We have witnessed a rapid increase in demand for our packaging solutions by pharmaceutical companies worldwide. This move will enable us to boost production capability and underpin our future growth.”

Untitled 3

LOG Pharma noted that its new clean room reinforces the company’s commitment to Good Manufacturing Practices (GMP) compliance for primary packaging quality assurance, full production control, and adherence to the highest manufacturing benchmarks in the industry.

The expansion reflects LOG’s strategic vision to enhance its production capabilities and maintain its competitive edge in the highly demanding pharmaceutical packaging market.

In addition to the Israel facility, the company also operates a manufacturing site in Hungary, strengthening its global footprint in the industry.

More For You

UK "medicines market is fundamentally broken

Drug manufacturers have seen a sharp rise in the money they have to pay the NHS

Pic credit: iStock

UK "medicines market is fundamentally broken,” says industry leadership group

The UK government have been accused of putting off investors in drug manufacturing over the “unsustainable levy” companies are having to pay the NHS.

Industry leaders have warned that the government’s growth plan will not succeed unless ministers commit to fixing a scheme which now requires companies to make record payments up to a quarter to a third (23.5 per cent-35.6 per cent) of a company’s revenue from sales of branded medicines to the NHS.

Keep ReadingShow less
Listeria outbreak: Cool Delight Desserts products removed from health care setting

The bacteria were detected in chocolate and vanilla and strawberry and vanilla flavoured mousse.

Cool Delight Desserts

3 deaths linked to listeria outbreak; NHS staff advised to withdraw Cool Delight Desserts products

NHS staff have been advised to remove all Cool Delight Desserts products from service and sales as a precautionary measure following the death of three people linked to a listeria outbreak.

The UK Health Security Agency (UKHSA) and Food Standards Agency (FSA) are investigating five cases of Listeria monocytogenes infection linked to the same strain of bacteria found in mousses supplied to NHS hospitals and care homes.

Keep ReadingShow less
Impact of National Insurance rise on community pharmacies.

Pharmacies are faced with higher NI payments

Pic credit: Istock

Pharmacies to pay higher national insurance contributions after MPs refuse to back amendments to bill


Community pharmacies are faced with paying the higher rate of national insurance contributions that come into force next month after MPs on Wednesday (19) rejected amendments to a bill that was approved by the House of Lords.

Keep ReadingShow less
Novo Nordisk regains ABPI membership after two-year suspension

Novo Nordisk was suspended in March 2023 for sponsoring pharmacy weight management training courses.

Image Credit: Novo Nordisk

Novo Nordisk’s ABPI suspension lifted after two years

Novo Nordisk has regained full membership of the Association of the British Pharmaceutical Industry (ABPI) after a two-year suspension due to serious breaches of the ABPI Code of Practice.

The reinstatement follows rigorous audits of the company’s compliance procedures and governance by the Prescription Medicines Code of Practice Authority (PMCPA).

Keep ReadingShow less
NICE calls for annual BMI checks for adults with long-term conditions

Annual BMI measurements create early intervention opportunities for weight management

Getty Images

NICE seeks feedback on annual BMI checks for adults with long-term conditions

The National Institute for Health and Care Excellence (NICE) has published a draft quality standard recommending annual Body mass index (BMI) and waist-to-height measurements for adults with long-term conditions to help prevent weight-related complications.

A consultation has been launched to gather feedback from healthcare professionals and commissioners on the feasibility of implementing these proposals within the NHS.

Keep ReadingShow less